171 related articles for article (PubMed ID: 10930709)
1. Botanical derivatives for the prostate.
Cristoni A; Di Pierro F; Bombardelli E
Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
3. Flavonoid and botanical approaches to prostate health.
Katz AE
J Altern Complement Med; 2002 Dec; 8(6):813-21. PubMed ID: 12614534
[TBL] [Abstract][Full Text] [Related]
4. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
5. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
Squadrito F; Morgia G
Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
[TBL] [Abstract][Full Text] [Related]
6. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
[TBL] [Abstract][Full Text] [Related]
7. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
8. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
[TBL] [Abstract][Full Text] [Related]
9. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
Mantovani F
Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
[TBL] [Abstract][Full Text] [Related]
10. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
11. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.
Ilic D; Misso M
Maturitas; 2012 Aug; 72(4):269-76. PubMed ID: 22633187
[TBL] [Abstract][Full Text] [Related]
12. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
13. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
[TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia.
Webber R
Clin Evid; 2006 Jun; (15):1213-26. PubMed ID: 16973049
[No Abstract] [Full Text] [Related]
15. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
16. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
Levin RM; Das AK
Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
[TBL] [Abstract][Full Text] [Related]
17. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
[TBL] [Abstract][Full Text] [Related]
18. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
[TBL] [Abstract][Full Text] [Related]
19. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
[TBL] [Abstract][Full Text] [Related]
20. Herbs for benign prostatic hyperplasia.
Dvorkin L; Song KY
Ann Pharmacother; 2002 Sep; 36(9):1443-52. PubMed ID: 12196065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
